Navigation Links
Asthma & Allergy Foundation CEO Appointed to NIH Council
Date:1/9/2009

BETHESDA, Md., Jan. 10 /PRNewswire-USNewswire/ -- The Asthma and Allergy Foundation of America (AAFA) announces that its President and CEO, William M. McLin, has been appointed to the Council of the National Institute of Allergy and Infectious Disease (NIAID), an institute of the National Institutes of Health (NIH), for a four-year term. The Council is a chartered advisory committee that provides a diverse perspective on science, health and the human impact of diseases.

The Council serves as NIAID's main advisory body on key functions, including: performing peer review, advising on policy, reviewing programs, and developing and clearing concepts for program announcements, requests for applications and requests for proposals. NIAID often seeks the Council's advice before changing policies for training, health information dissemination, administration, budget and other areas.

McLin has been head of AAFA since 2001 at a time when asthma and allergic diseases in the U.S. have experienced alarming growth; prevalence has nearly doubled over the past 25 years. McLin helped the 55-year-old not-for-profit patient group transition into the 21st Century to better educate patients and caregivers, as well as advocate and conduct research for the asthma and allergy community.

McLin will serve on the advisory subcommittee of the Division of Allergy, Immunology, and Transplantation through October 31, 2012. During program reviews, the subcommittee advises on a program's effectiveness in meeting Institute goals and the needs of the allergy and immunology community.

Before coming to AAFA, McLin served as Director of Government Relations and Executive Vice President during his 20-year tenure with the Epilepsy Foundation of America. He also provided interim executive oversight services to numerous nonprofit organizations. Mr. McLin has held key positions with the National Health Council, the American Society of Association Executives, the President's Committee for Employment of People with Disabilities and the Public Advisory Roundtable of the American Thoracic Society.

NIAID conducts and supports basic and applied research to better understand, treat and prevent infectious, immunologic and allergic diseases. For more than 50 years, NIAID research has led to new therapies, vaccines, diagnostic tests and other technologies that have improved the health of millions of people around the world. Visit www.niaid.nih.gov.

AAFA is the leading national not-for-profit patient advocacy organization for people with asthma and allergies. It is dedicated to improving the quality of life for people with asthma and allergies through education, advocacy and research. For more information, visit www.aafa.org.


'/>"/>
SOURCE The Asthma and Allergy Foundation of America
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Nitric Oxide Monitoring of Little Benefit for Kids Asthma
2. NO help: Nitric oxide monitoring does not help most children with asthma
3. American Asthma Foundation Announces Breakthrough Discovery
4. Antifungal Drug May Help Ease Asthma
5. Fungal pill could provide asthma relief for 150,000 UK sufferers
6. Anti-fungal drug offers great benefits to some with severe asthma
7. Mayo Clinic study finds increased risk of pneumococcal disease in asthma patients
8. School Program Helps Cut Asthma Risks
9. Antacid Medication in Pregnancy May Increase Childhood Asthma
10. Next Safety Develops an Air-Based Asthma Medication Inhaler That Does Not Use a Refrigerant Propellant
11. GlaxoSmithKline Statement on FDA Advisory Committee Vote on Use of Asthma Medicines Containing Long-Acting Beta-Agonists
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/16/2017)... Texas (PRWEB) , ... August 16, 2017 , ... Ten ... Credit Union's Stars in the Classroom and will win a visit by a Houston ... grades K-12 who are at least five years old can visit texanschecking.com/stars to nominate ...
(Date:8/16/2017)... ATLANTA, Georgia (PRWEB) , ... August 16, 2017 ... ... practice in Atlanta, opened their doors. They celebrate 30 years in business this ... to create an up-to-date, inviting, tranquil space to serve their patients. , ...
(Date:8/16/2017)... ... August 16, 2017 , ... Maury Regional Health has announced a ... By broadly deploying AccuVein devices, Maury Regional Medical Center is making vein visualization part ... of a needle stick and more importantly, helps our staff members locate a vein ...
(Date:8/16/2017)... New Cumberland, PA (PRWEB) , ... August 16, 2017 , ... ... announced today it has successfully opened clubfoot clinics in all 29 Indian states—bringing the ... its newest clinic in Kangra, Himachal Pradesh, the nonprofit organization is on track to ...
(Date:8/16/2017)... ... August 16, 2017 , ... Fusion Flix Inc., a Telly ... over four countries and millions of viewers in a partnership with the Amazon Video ... On-Demand and fully available on Blu Ray disc in 2018. Proceeds will be going ...
Breaking Medicine News(10 mins):
(Date:7/31/2017)... -- Three Tru-D SmartUVC robots have arrived at Brian Allgood ... Tru-D, short for "Total Room Ultraviolet Disinfection," is a 5-foot-5 germ-killing robot ... (ES) professional cleans the area with traditional cleaning protocols. ... Tru-D fights germs at Army hospitals ... "Although the BAACH has a very low infection rate, ...
(Date:7/27/2017)... -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today reported ... The Company reported second quarter net sales of $1.954 ... period, and an increase of 2.1% on a constant ... from the LDR Holding Corporation acquisition, second quarter 2017 ... or 0.3% on a constant currency basis. ...
(Date:7/26/2017)... BEACH, Fla. , July 26, 2017 ... of enrollment of our clinical trial evaluating Altemia TM ... Cell Anemia (SCA) and Sickle Cell Disease (SCD). The ... to evaluate the efficacy and safety of Altemia TM ... trial is conducted under US IND 125274. ...
Breaking Medicine Technology: